Clinical studies also support that decreased MTBP levels are correlated with increased metastasis and/or poor prognosis in gastric cancer, head and neck cancer, esophageal squamous cell carcinoma, and HCC [9,11,13,14]. The gene discussed is MTBP; the disease is gastric cancer.